About: Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2017 (fr) наукова стаття, опублікована в грудні 2017 (uk)
publication date	wds:Q57301962-20D9DD1C-305B-49EE-90D3-A56B5589EDB2
publication date	2017-12-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57301962-6EE98770-7750-43A4-8ADF-26E659DB4796
language of work or name	English
cites work	wds:Q57301962-07FC7FEC-43AF-4899-BEFC-C2F8A9CAB8AA wds:Q57301962-0BC0D335-8E0E-4BF3-84D4-BB6AD2DFF371 wds:Q57301962-0C3ED2E3-BD8E-46BF-BBDA-EA5B78365B1C wds:Q57301962-0C82BBA9-B269-44F6-A563-3DEBA0E00622 wds:Q57301962-11A964FA-1EC1-4733-AE5B-433E7425F021 wds:Q57301962-1340F783-419D-461A-B213-7E6888008C65 wds:Q57301962-2AF372DD-6C59-452B-821B-7D0A0A6EC864 wds:Q57301962-2CFB79D9-56AA-4AB9-8B60-0708A35A08E0 wds:Q57301962-2DADCF92-C15F-4836-A97D-0252F363E134 wds:Q57301962-399BA191-F1B0-4B0C-AD8F-4B7346B812D9 wds:Q57301962-3B779C2E-03C1-4B16-A098-B5BD476BC4B1 wds:Q57301962-3DC1D69A-EE7D-4671-920F-2E4AE97199A2 wds:Q57301962-4B8FBB42-ECAA-4AA3-A394-2FF79903A8DB wds:Q57301962-4F88A2B6-B2B1-480B-8C3A-A86C2A3B0DE3 wds:Q57301962-51C37AD6-B350-4046-9F58-35BB7212F4CD wds:Q57301962-56426E67-9132-4E0C-9A18-E2CBA7775B1A wds:Q57301962-58E43096-EA21-4F26-A910-364B0CC24D25 wds:Q57301962-80E398A0-8A1C-456E-9121-54B97F6FE9CF wds:Q57301962-9B20BDD8-A3A8-41DF-A8A0-C4452314EBAC wds:Q57301962-9C90B858-BB55-46C0-9D06-FF8A62CC141F wds:Q57301962-9E0207B8-C91D-4675-8EAC-6D9D1978CB41 wds:Q57301962-CA00D3DE-EB0E-4F37-8FFF-4344292CA6F1 wds:Q57301962-CBCFB766-502D-41DC-B8D4-B83BD9001DD4 wds:Q57301962-CC50EC72-E4FA-4E72-8E50-D5243FAD85AB wds:Q57301962-D65902E8-658C-48DC-9DC3-1139AC7EE2AE wds:Q57301962-D8428F76-1D02-44BA-872C-F6CC0DFD3041 wds:Q57301962-E4A3F3A9-E9BE-4E62-BC72-87A9D656B5EF wds:Q57301962-E8268E68-1AB4-4172-8760-892BB61BA849 wds:Q57301962-EA4F18F2-0A32-4E0E-B26A-4755E7089BB9 wds:Q57301962-F2201D52-8E4A-43FA-9EE8-5676745A1996 wds:Q57301962-FB8F0990-FC31-4FA0-866B-E9A88BE5602D
cites work	Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide Cognitive functions in survivors of primary central nervous system lymphoma. Long-term survival in primary CNS lymphoma Primary central nervous system lymphoma treated with high-dose methotrexate, high-dose busulfan/thiotepa, autologous stem-cell transplantation and response-adapted whole-brain radiotherapy: results of the multicenter Ostdeutsche Studiengruppe Hamato High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group. Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202). High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma. High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. A multicenter study of treatment of primary CNS lymphoma Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002. Long-term follow-up of high-dose chemotherapy with autologous stem-cell transplantation and response-adapted whole-brain radiotherapy for newly diagnosed primary CNS lymphoma: results of the multicenter Ostdeutsche Studiengruppe Hamatologie und Onko A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy Temporal trends in incidence of primary brain tumors in the United States, 1985-1999 Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group Isolated central nervous system relapse in aggressive non-Hodgkin's lymphoma: the Bologna experience Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Primary central nervous system lymphoma in Japan: changes in clinical features, treatment, and prognosis during 1985-2004. Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma. Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial. High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study
author name string	wds:Q57301962-125CC581-43FE-4D35-9E44-07E10845409B wds:Q57301962-43CA4239-E838-4A14-A3DC-A349A8EC5B28 wds:Q57301962-47F5D2BE-B0A3-4F0D-8149-E9D389B9C533 wds:Q57301962-77CF5811-5996-4DF6-A6DF-2FB2D34F0013 wds:Q57301962-8EF9709A-3301-4B43-8754-C5420DFD91C4 wds:Q57301962-961F6DB1-A8A3-40BB-B486-91A2A33D63A8 wds:Q57301962-9E3EFD6A-0EE6-4591-AE4E-03482FB70FEB wds:Q57301962-A08EB740-D31B-4976-BBEF-7EB73A8FF7BE wds:Q57301962-C6A7AC79-4C76-497E-B1A2-48509D0845CB wds:Q57301962-C888FF6E-986C-435B-A4B1-8C14DBFF18E2
author name string	Ran Reshef Stephen J Schuster Donald E Tsai Jakub Svoboda Sunita D Nasta Alex Ganetsky Daniel J Landsburg Nirav N Shah Sarah J Nagle Anthony Mato
rdfs:label	Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS (en) Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS (nl)
skos:prefLabel	Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS (en) Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS (nl)
name	Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS (en) Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS (nl)
title	wds:Q57301962-08882673-DA19-4E9C-8D01-DE2F24C82B7F
title	Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS (en)
page(s)	wds:Q57301962-A0BCCAC5-0950-47FB-8CB0-D13599AFD267
page(s)	113-121

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software